This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Anti Neurofilament L Antibody Market

Anti Neurofilament L Antibody Market By Type (Mouse Anti Neurofilament L Antibody, Rabbit Anti Neurofilament L Antibody), Application (Academic and Research Institutes, Pharma and Biotech Companies) & Region - Forecast 2022-2032

Market Insights on Anti Neurofilament L Antibody covering sales outlook, demand forecast & up-to-date key trends

Anti Neurofilament L Antibody Market Overview

The anti-neurofilament L antibody market is anticipated to showcase an incremental growth rate from 2022-2032 with an estimated CAGR of 11%. The anti-neurofilament L antibody market is likely to rise from US$ 145 Bn in 2022 to US$ 457 Bn by 2032.

The neurofilaments are the most common types of fibrillar components available in the axon.

As a result, the demand for anti-neurofilament L antibodies rises.

Attributes

Details

Anti-Neurofilament L Antibody Market CAGR

11%

Anti-Neurofilament L Antibody Market Size (2022)

US$ 145 Bn

Anti-Neurofilament L Antibody Market Size (2032)

US$ 457 Bn

In addition, the sales of anti-neurofilament L antibody are expected to surge owing to the frequency of usage of Neurofilaments being more than the axonal microtubules. 

The rising demand for anti-neurofilament L antibody can also be attributed to its usage in identifying the neurofilaments in the sample using a wide range of applications such as immunocytochemistry, immunohistochemistry, and western blotting. 

The anti-neurofilament L antibody can be derived from a number of hosts, including mice, rabbits, pigs’ chicken, and others, facilitating the demand for anti-neurofilament L antibody and mouse derived anti neurofilament L antibody are most commonly available. 

The thriving market of health care research and development is expected to experience a sharp drop in sales of anti-neurofilament L antibody during the lockdown period due to the shutdown of manufacturing units, a severe shortage of raw materials, and a lack of potential manpower. 

The current situation caused by the pandemic indicates that production and supply chain activities have encountered minor stumbling blocks. However, the market is expected to gradually recover following COVID-19, spiking the demand for anti-neurofilament L antibody in the coming years.

Customize this Report

Let us know your requirement to get
100% FREE customization

What Factors Influence the Anti-Neurofilament L Antibody Market Dynamics?

The rise in R&D investment globally, increase in research activities in Asia Pacific regions, and increased activities in neurological research are expected to drive up the demand for anti-neurofilament L antibody greatly.

A surge in the number of research labs also plays a vital role among the factors that contribute to the rising sales of anti-neurofilament L antibody during the forecast period.

However, stringent regulations for research poses several challenges that restrain the demand for anti-neurofilament L antibody in the near future.

Another factor impeding the sales of anti-neurofilament L antibody is ethical concerns about the use of animals in various countries.

How is the Anti-Neurofilament L Antibody Market Categorized?

The anti-neurofilament L antibody market is broadly classified based on host species, applications, and end users.

Host species include mice, rabbits, and others such as pigs and chickens.

The anti-neurofilament L Antibody market can be categorized into immunocytochemistry, immunohistochemistry, western blotting, and others.

These anti-neurofilament L antibody are generally used for research by academic and research institutes, pharma and biotech companies, and contract research organizations.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Region Holds the Highest Growth Potential in Anti-Neurofilament L Antibody Market?

Although North America and Europe hold the maximum anti-neurofilament L antibody market share, Asia Pacific is expected to be an equally lucrative region for the sales of anti-neurofilament L antibody owing to the rise in R&D expenditure.

Favorable government policies in the region, such as in China and Japan, can also be credited for the spike in demand for anti-neurofilament L antibody.

Thus, the anti-neurofilament L antibody market in the Asia Pacific region is expected to witness expanding sales of anti-neurofilament L antibody during the forecast period.

Who are the Key Players in the Anti-Neurofilament L Antibody Market?

Some of the key players in the anti-neurofilament L antibody market include Merck KGaA, BioLegend, Inc., Cell Signaling Technology, Inc., Rockland Immunochemicals Inc., Bio-Rad Laboratories, Inc., EnCor Biotechnology Inc., among others. 

Mergers, acquisitions, and expansions are the most commonly used strategies for persistent growth in the anti-neurofilament L antibody market to augment the anti-neurofilament L antibody market share.

The report consists of key players, contributing to the anti-neurofilament L antibody market share

It also consists of organic and inorganic growth strategies adopted by market players to surge the sales of anti-neurofilament L antibody in coming years.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Scope of Report

Report Attribute 

Details

CAGR

11%

Base year for estimation 

2021 

Historical data 

2014 - 2020 

Forecast period 

2022 - 2032 

Quantitative units 

Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 

Report coverage 

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis

Segments covered 

Type, application, region 

Regional scope 

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand 

Country scope 

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa 

Key companies profiled 

Merck KGaA, BioLegend, Inc., Cell Signaling Technology, Inc., Rockland Immunochemicals Inc., Bio-Rad Laboratories, Inc., EnCor Biotechnology Inc. among others.

Customization scope 

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. 

Pricing and purchase options 

Avail customized purchase options to meet your exact research needs.

Frequently Asked Questions

North America is anticipated to hold a large chunk of anti-neurofilament L antibody market share.

Merck KGaA, BioLegend, Inc., and Cell Signaling Technology, Inc. are considered as some of the key players in the anti-neurofilament L antibody market.

Stringent regulations for research is considered as a major factor restraining the demand for anti-neurofilament L antibody, in turn, the overall market growth.

Table of Content
Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Anti Neurofilament L Antibody Market